Dr. Harlan Andrew Pinto, MD is a Hematology / Oncology Specialist - Hematologist (Blood) practicing in Palo Alto, CA
He has not yet shared a personalized biography with Doctor.com.
| University | Degree | Focus | Graduated |
|---|---|---|---|
| Yale University School of Medicine | Medical Degree | 1983 |
| Institution | Focus | Year |
|---|---|---|
| Internship - Massachusetts General Hospital | 1984 | |
| Internship - Massachusetts General Hospital | 1984 | |
| Residency - Massachusetts General Hospital | 1986 | |
| Fellowship - Stanford University School of Medicine,Stanford, Ca, United States | 1991 |
| Certification | Cert. Body | Year |
|---|---|---|
Sub-Specialty: Medical Oncology | Internal Medicine | 1991 |
| Internal medicine | Internal Medicine | 1986 |
| Position | Organization | Time |
|---|---|---|
| Associate Professor of Medicine (Oncology) | the PAVAHCS and, by courtesy of Otolaryngology - Head & Neck Surgery at SUMC | Present |
| Publication | Publisher | Title | Published |
|---|---|---|---|
| Other Publication | HEAD AND NECK-JOURL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND N | INTENSITY-MODULATED RADIOTHERAPY FOR LOCALLY ADVANCED CANCERS OF THE LARYNX AND HYPOPHARYNX | 2011 |
| Other Publication | INTERTIOL JOURL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | INTENSITY-MODULATED RADIOTHERAPY IN THE TREATMENT OF OROPHARYNGEAL CANCER | 2010 |
| Other Publication | INTERTIOL JOURL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | In vivo H-1 magnetic resonce spectroscopy of lactate in patients with Stage IV head | 2008 |
| Other Publication | INTERTIOL JOURL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | Excellent local control with stereotactic radiotherapy boost after exterl beam radiotherapy | 2008 |
| Other Publication | JOURL OF THE TIOL CANCER INSTITUTE | Improved survival of patients with human papillomavirus-positive head | 2008 |
| Other Publication | HEAD AND NECK-JOURL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND N | Evaluation of patterns of failure | 2007 |
| Other Publication | JOURL OF NUCLEAR MEDICINE | Clinical role of F-18-FDG PET | 2007 |
| Other Publication | JOURL OF CLINICAL ONCOLOGY | Plasma osteopontin is an independent prognostic marker for head and neck cancers | 2006 |
| Other Publication | HEAD AND NECK-JOURL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND N | Advanced-staged tonsillar squamous carcinoma | 2006 |
| Other Publication | INTERTIOL JOURL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | Phase II double-blind r | 2004 |
| Other Publication | INTERTIOL JOURL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | Improved local control with stereotactic radiosurgical boost | 2003 |
| Other Publication | INTERTIOL JOURL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | Comparison of the comet assay | 2003 |
| Other Publication | ARCHIVES OF OTOLARYNGOLOGY-HEAD & NECK SURGERY | Estimating D repair by sequential evaluation of head | 2002 |
| Other Publication | AMERICAN JOURL OF NEURORADIOLOGY | In vivo H-1 MR spectroscopy of human head and neck lymph node metastasis and comparison with oxygen | 2000 |
| Other Publication | Neoplasia | D damage measured by the comet assay in head and neck cancer patients treated with tirapazamine. | 1999 |
| Other Publication | Tate, D. J., Adler, J. R., Chang, S. D., Marquez, S., Eulau, S. M., Fe | Stereotactic radiosurgical boost following radiotherapy in primary sopharyngeal carcinoma | 1999 |
| Other Publication | HEAD AND NECK-JOURL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND N | Tissue oxygen distribution in head and neck cancer patients | 1999 |
| Other Publication | AMERICAN JOURL OF SURGERY | Magement of the clinically positive neck in organ preservation for advanced head and neck cancer | 1998 |
| Other Publication | SEMIRS IN ONCOLOGY | Adjuvant and neoadjuvant treatment of head and neck cancers: The next chapter | 1995 |
| Other Publication | Macdold JS, Haller DG, Mayer RJ (eds), Manual of Oncologic Therapeutic | Head and neck cancers. | 1995 |
| Other Publication | HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND | INTENSITY-MODULATED RADIOTHERAPY FOR LOCALLY ADVANCED CANCERS OF THE LARYNX AND HYPOPHARYNX | 2011 |
| Other Publication | INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | INTENSITY-MODULATED RADIOTHERAPY IN THE TREATMENT OF OROPHARYNGEAL CANCER | 2010 |
| Other Publication | INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | In vivo H-1 magnetic resonance spectroscopy of lactate in patients with Stage IV head | 2008 |
| Other Publication | INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | Excellent local control with stereotactic radiotherapy boost after external beam radiotherapy | 2008 |
| Other Publication | JOURNAL OF THE NATIONAL CANCER INSTITUTE | Improved survival of patients with human papillomavirus-positive head | 2008 |
| Other Publication | HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND | Evaluation of patterns of failure | 2007 |
| Other Publication | JOURNAL OF NUCLEAR MEDICINE | Clinical role of F-18-FDG PET | 2007 |
| Other Publication | JOURNAL OF CLINICAL ONCOLOGY | Plasma osteopontin is an independent prognostic marker for head and neck cancers | 2006 |
| Other Publication | HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND | Advanced-staged tonsillar squamous carcinoma | 2006 |
| Other Publication | CANCER | Mature results from a randomized phase II trial of cisplatin plus 5 | 2006 |
| Other Publication | LARYNGOSCOPE | Positron-emission tomography for surveillance of head and neck cancer | 2005 |
| Other Publication | ARCHIVES OF OTOLARYNGOLOGY-HEAD & NECK SURGERY | Long-term results of 100 consecutive comprehensive neck dissections | 2004 |
| Other Publication | INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | Phase II double-blind r | 2004 |
| Other Publication | INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | Improved local control with stereotactic radiosurgical boost | 2003 |
| Other Publication | INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | Comparison of the comet assay | 2003 |
| Other Publication | CLINICAL CANCER RESEARCH | Identification of osteopontin as a prognostic plasma marker for head | 2003 |
| Other Publication | ARCHIVES OF OTOLARYNGOLOGY-HEAD & NECK SURGERY | Estimating DNA repair by sequential evaluation of head | 2002 |
| Other Publication | AMERICAN JOURNAL OF NEURORADIOLOGY | In vivo H-1 MR spectroscopy of human head and neck lymph node metastasis and comparison with oxygen | 2000 |
| Other Publication | Neoplasia | DNA damage measured by the comet assay in head and neck cancer patients treated with tirapazamine. | 1999 |
| Other Publication | Tate, D. J., Adler, J. R., Chang, S. D., Marquez, S., Eulau, S. M., Fe | Stereotactic radiosurgical boost following radiotherapy in primary nasopharyngeal carcinoma | 1999 |
| Other Publication | HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND | Tissue oxygen distribution in head and neck cancer patients | 1999 |
| Other Publication | LARYNGOSCOPE | Pretreatment and midtreatment measurement of oxygen tension levels in head and neck cancers | 1998 |
| Other Publication | AMERICAN JOURNAL OF SURGERY | Management of the clinically positive neck in organ preservation for advanced head and neck cancer | 1998 |
| Other Publication | Newman, J. P., Terris, D. J., Pinto, H. A., Fee, W. E., Goode, R. L., | Surgical morbidity of neck dissection after chemoradiotherapy in advanced head and neck cancer | 1997 |
| Other Publication | SEMINARS IN ONCOLOGY | Adjuvant and neoadjuvant treatment of head and neck cancers: The next chapter | 1995 |
| Other Publication | Cancer treatment and research | Distant metastases from head and neck squamous cancer: the role of adjuvant chemotherapy. | 1995 |
| Other Publication | Macdonald JS, Haller DG, Mayer RJ (eds), Manual of Oncologic Therapeut | Head and neck cancers. | 1995 |
| Other Publication | : Brian MC and Carbone PP (eds), Current Therapy in Hematology-Oncolog | Head and neck cancer - combined modality therapy and chemotherapy. | |
| Other Publication | HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA | CHEMOTHERAPY FOR RECURRENT AND METASTATIC HEAD AND NECK-CANCER | 1991 |
Dr. Harlan Andrew Pinto, MD has not yet indicated the hospitals that he is affiliated with.
Years In Practice: 34 (started in 1990)
Accepts New Patients: Yes
Dr. Harlan Andrew Pinto, MD has not yet listed the medications that he commonly prescribes.
Dr. Harlan Andrew Pinto, MD has not yet added any information about his practice's billing policies and payment options.
